ForteBio References in Literature. Overexpression of Cryoglobulin-Like Single-Chain Antibody Induces Morular Cell Phenotype via Liquid-Liquid Phase Separation in. Patentes Ponce Laura Grecia, Martínez Mejía Luz María, Ramírez Reivich Octavio Tonatiuh, Martínez Jiménez Alfredo, Bolívar Zapata Francisco Gonzalo, Gosset.

Background, Thrombolytic Agents, Thrombolytic Therapy for Acute Myocardial Infarction. Ouriel K. A history of thrombolytic therapy. J Endovasc Ther. 1. Suppl 2: II1. 28- 1. Sikri N, Bardia A. A history of streptokinase use in acute myocardial infarction.

PubMed comprises more than 27 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full.

Tex Heart Inst J. Hoffman R, Benz EJ, Shattil SJ, et al. Antithrombotic drugs. Hematology: Basic Principles and Practice. Philadelphia: Churchill Livingston Elsevier; 2. South San Francisco, CA: Genentech, Inc.

Available at . South San Francisco, CA: Genentech, Inc. Available at . Mc.

Pherson, KS: EKR Therapeutics, Inc. Available at . South San Francisco, CA: Genentech, Inc.

Available at . One- year follow- up of the ASSENT- 2 trial: a double- blind, randomized comparison of single- bolus tenecteplase and front- loaded alteplase in 1. ST- elevation acute myocardial infarction. Van De Werf F, Adgey J, Ardissino D, et al. Single- bolus tenecteplase compared with front- loaded alteplase in acute myocardial infarction: the ASSENT- 2 double- blind randomised trial. August 1. 99. 9. 3. Urokinase (Abbokinase, Kinlytic) . Tucson, Arizona: Ima.

Rx Therapeutics, Inc. Available at . Thrombolysis vs bleeding from hemostatic sites by a prourokinase mutant compared with tissue plasminogen activator. J Thromb Haemost. Streptokinase (Streptase) .

Ottawa, Ontario: CSL Behring Canada, Inc. Available at . Heart Disease and Stroke Statistics- 2. Update: A Report From the American Heart Association. Circulation. 2. 01. Jan 2. 6. 1. 33 (4): e.

Third Universal Definition of Myocardial Infarction. Circulation. 1. 26: 2. Appropriate cardiac cath lab activation: optimizing electrocardiogram interpretation and clinical decision- making for acute ST- elevation myocardial infarction.

ACCF/AHA Guideline for the Management of ST- Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 1. 27: e. Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction. Am J Cardiol. 1. 07(8): 1. Sgarbossa EB, Pinski SL, Babagelata A, et al.

Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle- branch block. Gusto- 1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators.

N Engl J Med. 3. 34(8): 4. Tabas JA, Rodr. Electrocardiographic criteria for detecting acute myocardial infarction in patients with left bundle branch block: a meta- analysis. Ann Emerg Med. 5. Concannon TW, Nelson J, Goetz J, et al. A percutaneous coronary intervention lab in every hospital? Circ Cardiovasc Qual Outcomes. Wang TY, Peterson ED, Ou FS, et al.

Door- to- balloon times for patients with ST- segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the national cardiovascular data registry. Chakrabarti AK, Gibson CM, Pinto DS. Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapy. Curr Opin Cardiol.

Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 3. 60(2. Di Mario C, Dudek D, Piscione F, et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS- in- AMI): an open, prospective, randomized, multicenter trial. COMMIT collaborative group. Addition of clopidogrel to aspirin in 4.

Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolysis therapy for myocardial infarction with ST- segment elevation. N Engl J Med. 3. 52(1. Antman EM, Morrow DA, Mc. Cabe CH, et al. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST- elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment- Thrombolysis In Myocardial Infarction study 2.

Ex. TRACT- TIMI 2. Kucher N, Goldwater SZ. Management of massive pulmonary embolism. Circulation. 1. 12(2): e. Fangled BT, Brady WJ. Fibrinolysis therapy in pulmonary embolism: an evidence- based treatment algorithm.

Am J Emerg Med. 2. Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines. Suppl): e. 41. 9S- e.

S. Management of Massive and Submissive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association. Circulation. 1. 23: 1. Fibrinolysis for acute care of pulmonary embolism in the intermediate risk patient. Curr Atheroscler Rep. Sharifi M, Bay C, Skrocki L, et al. Moderate Pulmonary Embolism Treated With Thrombolysis (from the . Am J Cardiol. 1. 11(2): 2. Dream Day True Love Full African more.

Bozbay M, Uyarel H, Avsar S, et al. Creatinine kinase isoenzyme- MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy. J Crit Care. 3. 0 (6): 1. Steering Committee. Single- bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Grunwald MR, Hofmann LV.

Comparison of urokinase, alteplase and reteplase for catheter- directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol.

Razavi MK, Wong H, Kee ST, et al. Initial clinical results of tenecteplase (TNK) in catheter- directed thrombolytic therapy. J Endovasc Ther. Parikh S, Motarjeme A, Mc. Namara T, et al. Ultrasound- accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience.

J Vasc Interv Radiol. Dumantepe M, Tarhan A, Yurdakul I, et al. US- accelerated catheter- directed thrombolysis for the treatment of deep venous thrombosis. Diagn Interv Radiol.

May- Jun 2. 01. 3. Baskin JL, Pui CH, Reiss U, et al. Management of occlusion and thrombosis associated with long- term indwelling central venous catheters. Thrombolytic therapy for central venous catheter occlusion. Haematologica. 9.

Katzan IL, Spertus J, Bettger JP, et al. Risk Adjustment of Ischemic Stroke Outcomes for Comparing Hospital Performance: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Effects of blood pressure and blood pressure- lowering treatment during the first 2.

Third International Stroke Trial of thrombolytic treatment for acute ischemic stroke. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt- PA Stroke Study Group. New Engl J Med. 3.

Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes. Murao K, Leys D, Jacquin A, et al.; for the OPHELIE- COG investigators. Thrombolytic therapy for stroke in patients with preexisting cognitive impairment. Jun 1. 0. 8. 2 (2.

IST- 3 collaborative group, Sandercock P, Wardlaw JM, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6h of acute ischaemic stroke (the third international stroke trial . Thrombolytic Therapy with streptokinase in acute ischemic stroke. The Multicenter Acute Stroke Trial - -Europe Study group. N Engl J Med. 3. 35(3): 1. Parsons MW, Miteff F, Bateman GA, et al.

Acute ischemic stroke: imaging guided tenecteplase treatment in an extended time window. Parsons M, Spratt N, Bivard A, et al. A randomized trial of tenecteplase and alteplase for acute ischemic stroke. N Engl J Med. 3. 66(1. Hacke W, Albers G, Al- Rawi Y, et al.